Roche and Spanish Collaborators to use 454 to Study Hepatitis Drug Resistance

The study will use 454 sequencing in conjunction with "other genetic and molecular analytical techniques" to profile hepatitis virus populations in individuals.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.